Search

Pradeep Tyagi

from Pittsburgh, PA
Age ~50

Pradeep Tyagi Phones & Addresses

  • 1012 Greenfield Ave, Pittsburgh, PA 15217 (412) 687-9767
  • 527 Aiken Ave, Pittsburgh, PA 15232 (412) 687-9767
  • 3245 Beechwood Blvd, Pittsburgh, PA 15217 (412) 687-9767
  • 5353 5Th St, Pittsburgh, PA 15232 (412) 687-9767
  • 5530 5Th St, Pittsburgh, PA 15232 (412) 687-9767
  • Royal Oak, MI

Work

Company: M/s samtel color ltd Dec 2013 Position: Sr.technician in plant

Education

School / High School: U.P. Board 2001 Specialities: second division

Resumes

Resumes

Pradeep Tyagi Photo 1

Assistant Professor

View page
Location:
Pittsburgh, PA
Industry:
Research
Work:
Uni.of Pitts
Assistant Professor
Education:
All India Institute of Medical Sciences 1997 - 1999
Master of Science, Masters
University of Pittsburgh
Skills:
Petroleum
Pradeep Tyagi Photo 2

Associate Professor Of Urology

View page
Location:
5530 5Th Ave, Pittsburgh, PA 15232
Industry:
Research
Work:
Oakland University Dec 2010 - Dec 2011
Associate Professor of Urology, William Beaumont School of Medicine

University of Pittsburgh School of Medicine Dec 2010 - Dec 2011
Associate Professor of Urology

Beaumont Health System Dec 2008 - Nov 2011
Director, Basic Urology Research

University of Pittsburgh School of Medicine Sep 2006 - Nov 2008
Assistant Professor
Education:
University of Pittsburgh 2000 - 2005
Doctorates, Doctor of Philosophy
National Institute of Pharmaceutical Education and Research 1999 - 2000
All India Institute of Medical Sciences 1997 - 1999
Master of Science, Masters, Pharmacology
Ccs (Chaudhary Charan Singh)University 1992 - 1996
Bachelors, Bachelor of Pharmacy, Pharmacy
Kendriya Vidyalaya 1986 - 1992
Skills:
Western Blotting
Cell Biology
Cell Culture
Molecular Biology
Biochemistry
Immunohistochemistry
Biotechnology
Immunology
Pcr
Elisa
Clinical Research
Confocal Microscopy
Immunofluorescence
Flow Cytometry
Clinical Trials
Lifesciences
Oncology
Biomedical Engineering
Teaching
Mass Spectrometry
Pradeep Tyagi Photo 3

Pradeep Tyagi

View page
Pradeep Tyagi Photo 4

Pradeep Tyagi

View page
Work:
M/S SAMTEL COLOR LTD

Dec 2013 to 2000
Sr.Technician in Plant

M/S SAMTEL COLOR LTD

Feb 2006 to 2000
Electrician apprentice

M/S SAMTEL COLOR LTD
Noida, Uttar Pradesh
Apr 2008 to Nov 2013
U.P. as Shift Technician maintenance in Engineering Department

M/S SAMTEL COLOR LTD

Feb 2007 to Apr 2008
Shift Technician

Education:
U.P. Board
2001
second division

Publications

Us Patents

Sphingomyelin Liposomes For The Treatment Of Hyperactive Bladder Disorders

View page
US Patent:
20070122466, May 31, 2007
Filed:
Oct 11, 2006
Appl. No.:
11/546025
Inventors:
Michael Chancellor - Pittsburgh PA, US
Pradeep Tyagi - Pittsburgh PA, US
Matthew Fraser - Apex NC, US
Yao-Chi Chuang - Kaohsiung Hsein, TW
William de Groat - Pittsburgh PA, US
Leaf Huang - Durham NC, US
Naoki Yoshimura - Pittsburgh PA, US
Assignee:
University of Pittsburgh - Pittsburgh PA
International Classification:
A61K 9/127
US Classification:
424450000
Abstract:
The present invention provides pharmaceutical compositions and methods for the instillation of lipid vehicles comprised of liposomes containing sphingomyelin or sphingomyelin metabolites to prevent, manage, ameliorate and/or treat disorders involving neuropathic pain and aberrant muscle contractions, such as what occurs in bladder hyperactivity disorders such as interstitial cystitis (IC) in animals or humans in need thereof. Also provided is a liposome-based delivery of drugs, e.g., antibiotics, pain treatments and anticancer agents, to the bladder, genitourinary tract, gastrointestinal system, pulmonary system and other organs or body systems. In particular, liposome-based delivery of vanilloid compounds, such as resiniferatoxin, capsaicin, or tinyatoxin and toxins, such as botulinum toxin is provided for the treatment of bladder conditions, including pain, inflammation, incontinence and voiding dysftunction.

Sphingomyelin Liposomes For The Treatment Of Hyperactive Bladder Disorders

View page
US Patent:
20120128762, May 24, 2012
Filed:
Jan 13, 2012
Appl. No.:
13/350326
Inventors:
Michael B. Chancellor - Pittsburgh PA, US
Pradeep Tyagi - Pittsburgh PA, US
Matthew O. Fraser - Apex NC, US
Yao-Chi Chuang - Niao-Sung Hsiang, TW
William C. de Groat - Pittsburgh PA, US
Leaf Huang - Durham NC, US
Naoki Yoshimura - Pittsburgh PA, US
International Classification:
A61K 9/127
A61K 31/575
A61K 31/683
A61K 31/70
A61P 13/10
A61K 31/685
US Classification:
424450, 514 78, 514 77, 514121, 514103, 514 23, 514171
Abstract:
The present invention provides pharmaceutical compositions and methods for the instillation of lipid vehicles comprised of liposomes containing sphingomyelin or sphingomyelin metabolites to prevent, manage, ameliorate and/or treat disorders involving neuropathic pain and aberrant muscle contractions, such as what occurs in bladder hyperactivity disorders such as interstitial cystitis (IC) in animals or humans in need thereof. Also provided is a liposome-based delivery of drugs, e.g., antibiotics, pain treatments and anticancer agents, to the bladder, genitourinary tract, gastrointestinal system, pulmonary system and other organs or body systems. In particular, liposome-based delivery of vanilloid compounds, such as resiniferatoxin, capsaicin, or tinyatoxin and toxins, such as botulinum toxin is provided for the treatment of bladder conditions, including pain, inflammation, incontinence and voiding dysfunction.

Sphingomyelin Liposomes For The Treatment Of Hyperactive Bladder Disorders

View page
US Patent:
20170290773, Oct 12, 2017
Filed:
Jun 21, 2017
Appl. No.:
15/629087
Inventors:
- Pittsburgh PA, US
Pradeep Tyagi - Pittsburgh PA, US
Matthew O. Fraser - Apex NC, US
Yao-Chi Chuang - Kaohsiung Hsein, TW
William C. de Groat - Pittsburgh PA, US
Leaf Huang - Durham NC, US
Naoki Yoshimura - Pittsburgh PA, US
International Classification:
A61K 9/127
A61K 9/00
Abstract:
The present invention provides pharmaceutical compositions and methods for the instillation of lipid vehicles comprised of liposomes containing sphingomyelin or sphingomyelin metabolites to prevent, manage, ameliorate and/or treat disorders involving neuropathic pain and aberrant muscle contractions, such as what occurs in bladder hyperactivity disorders such as interstitial cystitis (IC) in animals or humans in need thereof. Also provided is a liposome-based delivery of drugs, e.g., antibiotics, pain treatments and anticancer agents, to the bladder, genitourinary tract, gastrointestinal system, pulmonary system and other organs or body systems. In particular, liposome-based delivery of vanilloid compounds, such as resiniferatoxin, capsaicin, or tinyatoxin and toxins, such as botulinum toxin is provided for the treatment of bladder conditions, including pain, inflammation, incontinence and voiding dysfunction.
Pradeep Tyagi from Pittsburgh, PA, age ~50 Get Report